The Bill & Melinda Gates Foundation has committed an investment of $5 million to Bactofile, a specialist in gut microbiome health in the food and feed industry.
The funding will be used to accelerate the impact of Bactolife’s technology platform to develop binding proteins, a biologic solution to reduce the risk of gut infections in humans and animals.
Bactolife takes a unique approach to gut health for the greater good of humans and animals by developing breakthrough binding proteins that can reduce the risk of developing gut infections at an affordable price. With Bactolife’s technology platform and the investment made by the Bill & Melinda Gates Foundation, Binding Proteins can be formulated into food and feed products, making them easy to ingest.
